Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICL670 vs Deferoxamine in Sickle Cell Disease with Iron Overload
NCT00067080Phase 2Completed
- Sponsor
- Novartis
- Start
- May 2003
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of deferasirox in iron overload, sponsored by Novartis. Started May 2003; status: completed.
02
Drugs
deferasirox
03
Conditions
iron overload
Beyond the preview
Go deeper on NCT00067080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00067080.